medigraphic.com
ISSN 0016-3813 (Impreso)

2018, Número 6

<< Anterior Siguiente >>

Gac Med Mex 2018; 154 (6)


Las cardiopatías congénitas en el 2018

Vázquez-Antona C, Alva-Espinosa C, Yáñez-Gutierrez L, Márquez-González H

Idioma: Español
Referencias bibliográficas: 42
Paginas: 698-711
Archivo PDF: 486.36 Kb.


RESUMEN

Se presenta una actualización de los avances más relevantes de la ecocardiografía tridimensional para el diagnóstico de las cardiopatías congénitas. Se analiza la evolución de su tratamiento y se describen los resultados obtenidos en los últimos años. En el tema de la mujer embarazada con cardiopatía congénita se subrayan los cambios funcionales y estructurales durante el embarazo, así como los riesgos por considerar y la importancia del trabajo en equipo para tratar a estas enfermas. Finalmente se aportan datos de la situación en México y las medidas recomendadas para mejorarla.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Del Pasqua A, Sanders SP, De Zorzi A, Toscano A, Lacobelli R, Pierli C, et al. Impact of three-dimensional echocardiography in complex congenital heart defect cases: the surgical view. Pediatr Cardiol. 2009; 30:293‑300.

  2. Jenkins C, Monaghan M, Shirali G, Guraraja R, Marwick TH. An intensive interactive course for 3D echocardiography: is “crop till you drop” an effective learning strategy? Eur J Echocardiogr. 2008;9:373-380.

  3. Srivastava S, Printz BF, Geva T, Shirali GS, Weinberg PM, Wong PC, et al. Task force 2: pediatric cardiology fellowship training in noninvasive cardiac imaging: endorsed by the American Society of Echocardiography and the Society of Pediatric Echocardiography. J Am Soc Echocardiogr. 2015;66:687-698.

  4. Von Ramm OT, Smith SW. Real time volumetric ultrasound imaging system. J Digit Imaging. 1990;3:261-266.

  5. Vargas-Barrón J, Romero-Cárdenas A, Espínola N, Roldán Gómez FJ, Vázquez-Antona CA, Attie F, et al. Three-dimensional echocardiography in adult congenital heart disease. En: Nanda NC, Sorrell VL, editors. Atlas of three-dimensional echocardiography. EE. UU.: Futura Publishing; 2002.

  6. Vázquez-Antona CA, Muñoz L, Erdmenger J, Roldán J, Vargas J. Ecocardiografía tridimensional en la evaluación de los defectos cardiacos congénitos. Portuguese J Card. 2004;23 60.

  7. Vázquez-Antona, CA. Ecocardiografía tridimensional en cardiopatías congénitas. En: Martínez-Ríos MA, Damas De Los Santos F, Lorenzo- Negrete JA, editores. Contribuciones del Instituto Nacional de Cardiología Ignacio Chávez. México: Permanyer; 2014.

  8. De Castro S, Caselli S, Papetti F, Ventriglia F, Giardina A, Cavaretta E, et al: Feasibility and clinical impact of live three-dimensional echocardiography in the management of congenital heart disease. Echocardiography. 2006;23:553-556.

  9. Simpson J, Lopez L, Acar P, Friedberg M, Khoo N, Ko H, et al. Three-dimensional echocardiography in congenital heart disease: an expert consensus document from the European Association of Cardiovascular Imaging and the American Society of Echocardiography. Eur Heart J Cardiovasc Imaging. 2016;17:1071-1097.

  10. Roldán FJ, Vargas-Barrón J, Vázquez-Antona CA, Castellanos LM, Erdmenger-Orellana J, Romero-Cárdenas A, et al. Three dimensional transesophageal echocardiography of atrial septal defects. Cardiovasc Ultrasound. 2008;6:38.

  11. Balzer J, Van-Hall S, Böring YC, Kelm M. New role of echocardiography in the Cath Lab: novel approaches of peri-interventional 3D echocardiography. Curr Cardiovasc Imaging Rep. 2013;6:445-453.

  12. Kutty S, Colen TM, Smallhorn JF. Three-dimensional echocardiography in the assessment of congenital mitral valve disease. J Am Soc Echocardiogr. 2014;27:142-154.

  13. Pushparajah K, Barlow A, Tran VH, Miller OI, Zidere V, Vaidyanathan B, et al. A systematic three-dimensional echocardiographic approach to assist surgical planning in double outlet right ventricle. Echocardiography. 2013;30:234-238.

  14. Renella P, Marx GR, Zhou J, Gauvreau K, Geva T. Feasibility and reproducibility of three-dimensional echocardiographic assessment of right ventricular size and function in pediatric patients. J Am Soc Echocardiogr. 2014;27:903-910.

  15. Jurcut R, Giusca S, La-Gerche A, Vasile S, Ginhina C, Voigt JU. The echocardiographic assessment of the right ventricle: what to do in 2010? Eur J Echocardiogr. 2010;11:81-96.

  16. Gross RE, Hubbard JP. Surgical ligation of patent ductus arteriosus. Report of first successful case. JAMA. 1939;112:129.

  17. Moons P, Bovijn L, Budts W, Belmans A, Gewillig M. Temporal trends in survival to adulthood among patients born with congenital heart disease from 1970 to 1992 in Belgium. Circulation. 2010;122:2264-2272.

  18. Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M. Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation. 2014;130:749-756.

  19. Liebman J, Cullum L, Belloc NB. Natural history of transposition of the great arteries. Circulation. 1969;40:237-262.

  20. Frazer C. Resultados de switch para TGV. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu. 2017;20:38-42.

  21. Shim MS, Jun TG, Yang JH, Park PW, Kang IS, Huh J, et al. Current expectations of the arterial switch operation in a small volume center: a 20-year, single-center experience. Cardiothorac Surg. 2016;11:34.

  22. Campbell M. Natural history of atrial septal defect. Br Heart J. 1970;32:820-835.

  23. Lillehei CW, Cohen M, Warden HE, Varco RL. The direct vision intracardiac correction of congenital anomalies by controlled cross circulation; results in thirty-two patients with ventricular septal defects, tetralogy of Fallot, and atrioventricularis communis defects. Surgery. 1955;38:11-29.

  24. Téllez-De Peralta G. Historia de la cirugía cardiovascular. En: Tratado de cirugía cardiovascular. España: Sociedad Española de Cardiología; 1999.

  25. Moore JW, Vincent RN, Beekman RH, Benson L, Bergersen L, Holzer R, et al. Procedural results and safety of common interventional procedures in congenital heart disease: initial report from the National Cardiovascular Data Registry. J Am Coll Cardiol. 2014;64:2439-2451.

  26. Bertranou EG, Blackstone EH, Hazelrig JB, Turner ME, Kirklin JW. Life expectancy without surgery in tetralogy of Fallot. Am J Cardiol. 1978; 42:458-466.

  27. Caruana M, Grech V. A first population-based long-term outcome study in adults with repaired tetralogy of Fallot in Malta. Congenit Heart Dis. 2017;12:301-308.

  28. Starr JP. Tetralogy of Fallot: yesterday and today. World J Surg. 2010;34:658-668.

  29. Cuypers JA, Menting ME, Konings EE, Opić P, Utens EM, Helbing WA, et al. Unnatural history of tetralogy of Fallot: prospective follow-up of 40 years after surgical correction. Circulation. 2014;130:1944-1953.

  30. Kempny A, Dimopoulos K, Uebing A, Diller GP, Rosendahl U, Belitsis G, et al. Outcome of cardiac surgery in patients with congenital heart disease in England between 1997 and 2015. PLoS One. 2017; 12:e0178963.

  31. Rubio-Álvarez V, Limón RL. Valvulotomía intracardiaca por medio de un catéter. Arch Inst Cardiol Mex. 1953;23:183-192.

  32. Marelli AJ, Therrien J, Mackie AS, Ionescu-Ittu R, Pilote L. Planning the specialized care of adult congenital heart disease patients: from numbers to guidelines; an epidemiologic approach. Am Heart J. 2009;157:1-8.

  33. Gilboa SM, Devine OJ, Kucik JE, Oster ME, Riehle-Colarusso T, Nembhard WN, et al. Congenital heart defects in the United States: estimating the magnitude of the affected population in 2010. Circulation. 2016;134:101‑109.

  34. Alva-Espinosa C. Ante el adulto con cardiopatía congénita. Arch Cardiol Mex. 2006;76:57-61.

  35. Knight M, Nair M, Tuffnell D. Saving lives, improving mothers’ care. EE. UU.: University of Oxford; 2016.

  36. Canobbio MM, Perloff J, Rapkin AJ. Gynecological health of females with congenial heart disease. Int J Cardiol. 2005;98:379-387.

  37. 37 Uebing A, Steer P, Yentis S, Gatzoulis M. Pregnancy and congenital heart disease. BMJ. 2006;332:401-406.

  38. Van Hagen I, Boersma E, Johnson M. Global cardiac risk assessment in the registry of pregnancy and cardiac disease: Results of a registry from the European Society of Cardiology. Eur J Heart Fail. 2016;18:523- 533.

  39. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R. De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39(34): 3165–3241.

  40. Calderón-Colmenero J, De La Llata M, Vizcaíno A, Ramírez-Marroquín S, Bolio-Cerdán A, Alva C, et al. Medical and surgical health care for congenital heart disease: a panoramic vision of the reality in Mexico. Inquiry 2009. Rev Invest Clin. 2011;63;344-352.

  41. Márquez-González H, Yáñez-Gutiérrez L, Rivera-May JL, López-Gallegos D, Almeida-Gutiérrez E. Demographic analysis of a congenital heart disease clinic of the Mexican Institute of Social Security, with special interest in the adult. Arch Cardiol Mex. 2017;pii:S1405-9940.

  42. Instituto Nacional de Estadística y Geografía. Principales resultados de la Encuesta Intercensal 2015. Estados Unidos Mexicanos. México: INEGI; 2015. Disponible en: http //internet.contenidos.inegi.org.mx/contenidos/ productos/prod_serv/contenidos/espanol/bvinegi/productos/nueva_ estruc/702825078966 pdf




2020     |     www.medigraphic.com